Acknowledgements
ONCOLOGY
We thank the patients and families who made this trial possible, clinical study teams involved in the study, as well as the data and safety monitoring members. Professional medical writing and editorial assistance was provided by Ashfield MedComms, an Inizio company, funded by Taiho Oncology, Inc.